13F filing recap · Q4 2015
What did First Eagle Investment Management buy in Q4 2015?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every First Eagle account, including accounts that belong to no fund below.
Stock value
$39.99B
Positions
328
Estimated turnover
30.1%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
GOOGLAlphabet Inc.$410.68Mreported value+527.9K sharesGOOGAlphabet Inc.$173.65Mreported value+228.8K sharesHPEHewlett Packard Enterprise Company$144.94Mreported value+9.54M sharesMSGSMadison Square Garden Sports Corp.$135.88Mreported value+839.8K sharesCMICummins Inc$126.17Mreported value+1.43M sharesWFMWhole Foods Market Inc.$63.98Mreported value+1.91M sharesBIIBBiogen Inc.$59.40Mreported value+193.9K sharesQCOMQualcomm Inc/de$51.16Mreported value+1.02M sharesCSXCsx Corporation$48.45Mreported value+1.87M sharesPKGPackaging Corp of America$40.83Mreported value+647.5K sharesITCItc Holdings Corp.$31.14Mreported value+793.3K sharesMSTRStrategy Inc$20.67Mreported value+115.3K sharesSPYSPDR S&P 500 ETF Trust$18.89Mreported value+92.7K sharesDCPDcp Midstream, LP$17.78Mreported value+720.8K sharesCRDFCardiff Oncology, Inc.$2.03Mreported value+376.1K sharesCALACalithera Biosciences Inc$1.57Mreported value+205.4K sharesCPXXCelator Pharmaceuticals, Inc.$1.08Mreported value+612.6K sharesVBLTVascular Biogenics Ltd.$1.03Mreported value+196.0K sharesONTYOncothyreon Inc$666.0Kreported value+300.0K sharesAGRAvangrid Inc$614.0Kreported value+16.0K sharesAPUAmerigas Partners, L.p.$336.0Kreported value+9.8K sharesXYZBlock, Inc.$25.0Kreported value+1.9K sharesTSLATesla, Inc.$25.0Kreported value+105 sharesKLDXKlondex Mines Ltd.$10.0Kreported value+5.0K shares